Chemotherapy and drug resistance status of malaria parasite in northeast India

  • Diganta G
  • Indra B
  • Sunil D
  • et al.
ISSN: 1995-7645
Citations of this article
Mendeley users who have this article in their library.


India reports the highest number of malaria cases in Southeast Asia, of which Plasmodium falciparum contribute more than half of the cases every year. North eastern states of India contribute only 3.96% of country's population but account for >10% of total reported malaria cases, 11% of Plasmodium falciparum cases and 20% of malaria related deaths annually. In India, chloroquine resistance was reported for the first time from northeast region and since then chloroquine treatment failure is being reported from many parts of the region. Increased chloroquine treatment failure has led to change of the drug policy to artemisinin combination therapy as first line of malaria treatment in the region. However, replacing chloroquine to artemisinin combination therapy has not shown significant difference in the overall malaria incidence in the region. The present review addresses the current malaria situation of northeastern region of India in the light of antimalarials drug resistance.




Diganta, G., Indra, B., Sunil, D., Bipul, R., Vijay, V., Lokendra, S., & Sharma, D. K. (2013). Chemotherapy and drug resistance status of malaria parasite in northeast India. Asian Pacific Journal of Tropical Medicine, 6, 583–588. Retrieved from email:

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free